Mobile

A study evaluating the effect of a chemotherapy regimen on the menstrual and ovarian functions of young breast cancer patients

Update Il y a 4 ans
Reference: EUCTR2013-000173-77

Woman Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

- Evaluate the impact of a cyclophosphamide-free regimen on the ovarian function recovery defined as menstrual resumption within 12 months following the end of chemotherapy - Evaluate the impact of a cyclophosphamide-free regimen on the development of ovarian failure defined as serum FSH >40 IU/L at 12 months following the end of chemotherapy

Inclusion criteria

  • Primary breast cancer (adjuvant or neoadjuvant)

Links